胺碘酮联合β受体阻滞剂治疗急性心肌梗死并发室性快速心律失常的效果  

Effects of Amiodarone combined withβ-blockers in treatment of acute myocardial infarction complicated with ventricular tachyarrhythmia

作　　者：杨勇 YANG Yong(Department of Cardiology of Fuxin Central Hospital,Fuxin 123000 Liaoning,China)

机构地区：[1]阜新市中心医院心内科,辽宁阜新123000

出　　处：《中国民康医学》2020年第15期8-10,共3页Medical Journal of Chinese People’s Health

摘　　要：目的:探讨胺碘酮联合β受体阻滞剂治疗急性心肌梗死(AMI)并发室性快速心律失常的临床效果.方法:选取70例AMI伴室性快速心律失常患者,按照随机数字表法分为观察组与对照组各35例,对照组采用艾司洛尔注射液+美托洛尔片治疗,观察组在对照组基础上联合胺碘酮治疗.比较两组临床疗效、不良反应发生率及病死率.结果:观察组总有效率为94.29%(33/35),高于对照组的74.29%(26/35),差异有统计学意义(P<0.05);两组不良反应发生率比较,差异无统计学意义(P>0.05);观察组无死亡病例,对照组病死率为11.43%.结论:胺碘酮联合β受体阻滞剂治疗AMI伴室性快速心律失常患者效果优于单用β受体阻滞剂,可降低病死率,且安全性高.Objective:To analyze effects of Amiodarone combined withβ-blockers in treatment of acute myocardial infarction(AMI)complicated with ventricular tachyarrhythmia.Methods:70 patients with AMI complicated with ventricular tachyarrhythmia were selected and divided into observation group and control group according to the random number method,35 cases in each group.The control group was treated with Esmolol injection+Metoprolol tablets,while the observation group was treated with Amiodarone on the basis of those of the control group.The clinical efficacy,incidence of adverse reactions and mortality were compared between the two groups.Results:The total effective rate of the observation group was 94.29%(33/35),which was higher than 74.29%(26/35)of the control group,and the difference was statistically significant(P<0.05).There was no significant difference in the incidence of adverse reactions between the two groups(P>0.05).There was no death in the observation group,and the mortality rate in the control group was 11.43%.Conclusions:Amiodarone combined withβ-blockers is more effective thanβ-blockers in the treatment of the patients with AMI complicated with ventricular tachyarrhythmia.Moreover,it can reduce the mortality rate and has high safety.

关 键 词：快速心律失常 艾司洛尔 胺碘酮 急性心肌梗死 

分 类 号：R541.76[医药卫生—心血管疾病]